EDGAR Filing Documents for 0001193125-20-052872

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-20-052872

Filing Date

2020-02-27

Accepted

2020-02-27 16:51:38

Documents

Effectiveness Date

2020-02-27

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	d893269ds8.htm	S-8	57012
2	EX-5.1	d893269dex51.htm	EX-5.1	12400
3	EX-23.1	d893269dex231.htm	EX-23.1	2518
4	GRAPHIC	g893269dsp07.jpg	GRAPHIC	3014
5	GRAPHIC	g893269dsp8.jpg	GRAPHIC	1978
	Complete submission text file	0001193125-20-052872.txt		80103

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-236711 | Film No.: 20663166
SIC: 2834 Pharmaceutical Preparations